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Defined by Antiganglioside Monoclonal Antibody 3G5
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Despite multiple functional alterations of T cells with advancing age, standard
mAb-defined T cell subsets are remarkably constant from youth to old age (1).
In this communication we describe a novel "resting" human T cell subset defined
by mAb 3G5 . mAb 3G5 was originally produced after the immunization of
C57BL6 x BALB/c mice with fetal rat brain (2). This cytotoxic IgMK mAb reacts
with a ganglioside(s) expressed on the surface of a series of hormone-secreting
cells, including pancreatic islets, a subset of anterior pituitary cells, and adrenal
medullary cells (2).
Studies defining the relationship of this . T cell subset to aging in man are
described in this report.
Materials and Methods
T Cell Studies.
￿
To determine the percentage of 3G5+ T cells in the peripheral blood
and the possible existence of a relationship to aging we isolated T cells from the circulation
of 21 normal individuals (ages 7-84) and determined the percentage ofperipheral T cells
reacting with mAbs 3G5, OKT4 (helper), and OKT8 (suppressor/cytotoxic) using a flow
cytometer (3). In addition, we assessed the percent 3G5+ T cells in nine pairs of
monozygotic twins (ages 11-58). Heparinized venous blood was collected and the mono-
nuclear cells separated by Ficoll-Hypaque density centrifugation. Purified T cells were
obtained by incubating the mononuclear cells with neuraminidase-treated sheepred blood
cells overnight at 4°C. The resultant rosettes were separated by repeat Ficoll-Hypaque
density centrifugation followed by hypotonic lysis of the sheep red blood cells. The
resultant T cell preparation was washed with RPMI 1640. 1-2 x 106 T cells were
incubated at 4'C for 45 min with the appropriate mAb antibody and then washed twice
with RPMI 1640 . A second incubation was then performed with fluoresceinated goat
anti-mouse Ig (Tago Inc., Burlingame, CA), followed by two additional washes with
RPMI 1640. Consent for blood drawing was obtained from all individuals.
Neuraminidase Treatment.
￿
Human T cellsas prepared above were exposed to 10 U/ml
of neuraminidase (Sigma Chemical Co., St. Louis, MO) for 45 min at 37°C. Binding to
mAb 3G5 or control monoclonal A2B5 was assessed by the methods above.
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Ganglioside Preparation and ELISA.
￿
A Folch preparation of lipids was made from 108
human T cells (4). T cells were extracted with chloroform/methanol/water 1 :2:1 .4
(vol/vol) and the aqueous phase was removed and evaporated. The residue was dissolved
in chloroform/methanol/water 60:30:4.5 (vol/vol), and after centrifugation the superna-
tant fraction was dialyzed against distilled water, lyophilized, and resuspended in methanol,
aliquoted into a microtiter plate, and dried under a flow of gaseous nitrogen. Under these
conditions purified gangliosides adsorb to microtiter wells. mAb 3G5 or control antibody
P3X63 were then placed in each well and the microtiter plates were incubated at 4°C for
45 min. The plate was washed and peroxidase-conjugated rabbit anti-mouse Ig was
incubated in each well for 30 min at room temperature. The wells were then washed and
the color reaction was developed with hydrogen peroxide and o-phenylenediamine; the
optical density was read at 492 nm .
TLC and Direct Immunostaining of Chromatograms.
￿
Immunostaining of TLCs was
performed using an immunoperoxidase based modification of the method of Magnani
(5). Briefly, a ganglioside preparation as above (from ^-108 sheep erythrocyte-rosetted
human T cells) was divided into two lanes on an aluminum-backed high-performance
TLC plate and separated by ascending chromatography in chloroform/methanol/KCI
(0.25%; aqueous) 5:4:1 . The plate was immersed for 90 s in a saturated solution of
polyisobutyl methacrylate in hexane and then air dried. The plate was then incubated in
PBS/3% BSA for 1 h. The lanes were subsequently reacted with either mAb 3G5 or
control antibody P3X63 at a 1 :250 dilution in PBS/3% BSA for 2 h, were given three 5-
min washes in PBS/3% BSA, and were incubated for 90 min in horse radish peroxidase-
conjugated rabbit anti-mouse Ig (1 :100), followed by three 5-minute washes in PBS/3%
BSA. Horse radish peroxidase-conjugated swine anti-rabbit Ig was then added as above.
The color reaction was developed with 40 mg 4-chloro-l-naphthol in 50 ml of 50 mM
Tris, pH 7.4, containing 0.012% H202.
Results
A clear relationship between age and the percentage of circulating 3G5+ T
lymphocytes was found in normal human subjects (r = 0.85, p < 0.001 ; Fig. 1).
The percentage of circulating T cells reacting with mAb 3G5 increased linearly
from age 7 (23-30%) to age 84 (58%) . In contrast, the percentage of OKT4*
(Leu-3) and OKT8+ (Leu-2) T cells did not vary with age (Fig. 1). The percent
3G5+ T cells in pairs of monozygotic twins showed a high degree of correlation
(r = 0.840, p < 0 .005 ; Fig. 2). The 3G5' T cell subset was further characterized
using directly fluoresceinated 3G5 and phycoerythrin-conjugated Leu-2 (sup-
pressor/cytotoxic cells) and Leu-3 (helper cells). The majority of the 3G5' T
cells were Leu-3+ cells (73%) and 17% were Leu-2+ cells. Of the Leu-2+
circulating cells, 24% were 3G5+ and of the Leu-3' cells, 45% were 3G5+. The
3G5 antibody did not bind to nonrosetting mononuclear cells as shown by
immunofluorescent detection.
To determine whether 3G5 represented an activation antigen associated with
aging, the percentage of cells reacting with monoclonal 3G5 were quantitated
after PHA (2 ktg/ml) stimulation. In each of three experiments the percentage
of 3G5+ cells decreased after incubation with PHA as compared with control
cultures. We found decrements of up to 90% in percentage of cells expressing
the 3G5 antigen.
To determine whether the antigen on T cells is biochemically similar to that
on neuroendocrine cells we treated T cells with purified neuraminidase, which
removes terminal sialic acid residues of glycoproteins and gangliosides. Neura-1438
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minidase-treatedTcellsfailed toreactwith antibody 3G5. Thebindingdecreased
to that of the nonspecific negative control (AM) (Fig. 3).
To further characterize the antigen, a Folch preparation ofTcell gangliosides
was adsorbed to microtiter wells. An ELISAusingmAb 3G5andcontrolantibody
P3X63 was prepared. The optical density was 0.135 ± 0.003 for wells incubated
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FIGURE 3 . The binding of mAb 3G5 to
purified human peripheral T cells (assessed
by FACS analysis) is shown in the top panel
(method as per Fig. 1) . Nonspecific binding
was assessed by a negative control (monoclo-
nal A2B5) . After exposure of T cells to
neuraminidase, the binding of 3G5 is lost
(bottom) . Log integral green fluorescence is
plotted on the abscissa. Relative cell number
is plotted on the ordinate for each graph .
FIGURE 4.
￿
Thin layer chromatogram ofaT cell ganglioside prep-
aration stained with control mAb P3X63 (1) and 3G5 (2). The 3G5
ganglioside migrates between the GM 1 and GM2 markers.
with antibody 3G5, exceeding the control (0.08 ± 0.009 ; p < 0.001), which
indicated the presence of 3G5 antigen(s) in the purified ganglioside preparation
(6). We were unable to demonstrate aT cell protein reacting with antibody 3G5
on Western blots after PAGE . UsingTLC the 3G5 antigen ofhuman E-rosetted
T cells migrates below GM2 and above GM 1 (Fig . 4) . The possibility of the
detected antigen originating from the sheep erythrocytes was excluded by the
detection of the same antigen in extracts of peripheral blood mononuclear cells
before rosetting ; furthermore, 3G5 did not bind to sheep erythrocytes, as shown
by indirect immunofluorescence (data not shown) .
Discussion
The percentage of circulating 3G5+ T cells increases linearly with advancing
age in normal individuals, while the percentage of OKT4 (helper-inducer) and
OKT8 (suppressor/cytotoxic) cells did not vary with age . As might be expected1440
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in individuals of the same age and phenotype, the monozygotic twin pairs showed
a strong correlation for percent 3G5+ T cells. 3G5+ T cells are both OKT4+ and
OKT8+ and decrease after PHA activation. Whether the increase in the propor-
tion of T cells expressing 3G5 reflects biosynthesis of the 3G5 antigen or the
uncovering of a previously cryptic antigen with age remains to be elucidated.
mAb 3G5 reacts with a ganglioside on neuroendocrine cells (2). The antigen
reacting with 3G5 on the surface of T cells appeared also to be a ganglioside, in
that treatment of T cells with purified neuraminidase abrogated antibody 3G5
binding, antigenic material could be extracted with chloroform/methanol and
partitioned into the methanol-water phase of a Folch preparation, the mAb 3G5
reacted with a band migrating between GM 1 and GM2 ganglioside markers on
TLC, and we were unable to demonstrate a T cell protein reacting with antibody
3G5 on Western blots after PAGE .
Gangliosides are glycosphingolipids containing sialic acid. They have hydro-
phobic and hydrophilic regions and are positioned in cell membranes with the
sialic acid containing carbohydrate backbone exposed to the extracellular envi-
ronment. Possible roles for gangliosides include function as receptors for hor-
mones, toxins, and viruses, cell-cell adhesion, and synaptic transmission (7-10).
The remarkable diversity of cell-surface glycoconjugates and their regulation
with cellular differentiation have been increasingly appreciated (11). Although
once considered primarily neural antigens, gangliosides are present on thymic
epithelium, red bloodcells, pancreatic islets, kidney glomeruli, and malignancies,
including melanoma and neuroblastoma, and as shown in this study of human T
lymphocytes(12-15). The presence ofgangliosides on the surface ofthese diverse
cell types suggest a common though currently unknown function. 3G5+ cells
represent the first T cell subset that reflects aging in man, and we speculate that
its increase may be related to the increased prevalence of autoimmunity with
aging since we have observed an abnormal increase in the percentage of 3G5+
T cells in patients with amidarone-induced thyroid autoimmunity and Type I
diabetes (16, 17).
Summary
A new human T cell subset defined by antineuronal ganglioside mAb 3G5
increases linearly with advancing age in man. The percentage of circulating
3G5' T cells in 21 normal individuals, quantitated by cytofluorograph analysis,
increases linearly from age 7 (23-30%) to age 84 (58%) (r = 0.85, p < 0.001).
The antigen on T cells has the biochemical properties of a ganglioside that
migrates between GM 1 and GM2 ganglioside markers on TLC. The 3G5 subset
represents the first T cell subset that reflects aging in man.
Received forpublication 1 December 1986 and in revisedform IS February 1987.
References
1. Nagel, J. E., F. J. Chrest, R. S. Pyle, and W. H. Adler. 1983 . Monoclonal antibody
analysis, T lymphocyte subsets in youngand aged adults. Immunol. Commun. 12 :223 .
2. Powers, A. C., A. Rabizadeh, R. Akeson,andG. S. Eisenbarth. 1984. CharacterizationRABINOWE ET AL.
￿
BRIEF DEFINITIVE REPORT
￿
144 1
ofmonoclonal antibody 3G5 and utilization of this antibody to immobilize pancreatic
islet cell gangliosides in a solid phase radioassay. Endocrinology. 114:1 .
3 . Reinherz, E. L., and S. F. Schlossman . 1980. The differentiation and function of
human T lymphocytes. Cell. 19:821 .
4. Svennerholm, L., and P. Fredman . 1980. A procedure for isolation of brain ganglio-
sides. Biochim. Biophys. Acta. 617:97.
5 . Magnani, J. L., M . Brokhaus, D. F. Smith, and V. Ginsburg. 1982 . Detection of
glycolipid ligands by direct binding of carbohydrate binding proteins to thin layer
chromatograms. Methods Enzymol. 83 :236.
6 . Posner, M. R., D. Antoniou, J . Griffin, S. F. Schlossman, and H. J. Lazarus. 1982.
An enzyme linked immunosorbent assay (ELISA) for the detection of monoclonal
antibodies to cell surface antigens on viable cells. J. Immunol. Methods. 48:23.
7 . Weigandt, H. 1982. The gangliosides. Adv. Neurochem. 4:149.
8 . Fishman, P. H., and R. D. Brady. 1976. Biosynthesis and function of gangliosides.
Science (Wash. DC). 194:906.
9 . Valente, W. A., P. Vitti, Z. Yavin, C. M. Rotella, E. F. Grollman, R. S. Torcafondi,
and L. D. Kohn. 1982. Monoclonal antibodies to the thyrotropin receptor: stimulating
and blocking antibodies derived from the lymphocytes ofpatients with Graves disease.
Proc. Natl. Acad. Sci. USA. 79:6680.
10 . Markwell, M. A., L. Svennerholm, and J. C. Paulson. 1981 . Specific gangliosides
function as host cell receptors for Sendai virus. Proc. Natl. Acad. Sci. USA. 78 :5406.
11 . Feizi, T. 1985. Demonstration by monoclonal antibodies that carbohydrate structures
of glycoproteins and glycolipids are onco-developmental antigens. Nature (Lond.).
314:53.
12. Eisenbarth, G. S., K. Shimizu, M. A. Bowring, and S . Wells. 1982. Expression of
receptors for tetanus toxin and monoclonal A2B5 by pancreatic islet cells. Proc. Natl.
Acad. Sci. USA. 79:5066 .
13. Haynes, B. F., K. Shimizu, and G. S. Eisenbarth . 1983 . Identification of human and
rodent thymic epithelium using tetanus toxin and monoclonal antibody AM. J.
Clin. Invest. 71 :9.
14. Pukel, C. S., K. O. Lloyd, L. R. Travassos, W. G. Dippold, H . F. Oettgen, and L. J.
Old. 1982. GD3, a prominent ganglioside of human melanoma. Detection and
characterization by mouse monoclonal antibody. J. Exp. Med. 155:1133.
15. Kemshead, J. T., F. S. Walsh, J. Pritchard, and M. Greaves. 1981 . Monoclonal
antibody to ganglioside GQ discriminates between hematopoietic stem cells and
infiltrating neuroblastoma tumor cells in bone marrow. Int. J. Cancer. 27 :447.
16. Rabinowe, S. L., P. R. Larsen, E. M. Antman, K. L . George, P. L. Friedman, R. A.
Jackson, and G. S. Eisenbarth. 1986 . Autoimmune thyroid disease: evaluation of a
new monoclonal antibody defined T cell subset. Am. J. Med. 81 :53 .
17. Rabinowe, S. L., K. George, and R. Jackson. 1985. Lymphocyte abnormalities in
individuals prior to overt diabetes mellitus or at risk for Type I diabetes mellitus.
Diabetes. 34:268. (Abstr.)